175 related articles for article (PubMed ID: 29706109)
1. Factors influencing access to palliative radiotherapy: a Norwegian population-based study.
Åsli LM; Myklebust TÅ; Kvaløy SO; Jetne V; Møller B; Levernes SG; Johannesen TB
Acta Oncol; 2018 Sep; 57(9):1250-1258. PubMed ID: 29706109
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy for women with breast cancer.
Danielson B; Winget M; Gao Z; Murray B; Pearcey R
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):506-12. PubMed ID: 18524556
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the use of palliative radiotherapy in Ontario.
Huang J; Zhou S; Groome P; Tyldesley S; Zhang-Solomans J; Mackillop WJ
J Clin Oncol; 2001 Jan; 19(1):137-44. PubMed ID: 11134206
[TBL] [Abstract][Full Text] [Related]
5. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study.
Lavergne MR; Johnston GM; Gao J; Dummer TJ; Rheaume DE
Palliat Med; 2011 Mar; 25(2):101-10. PubMed ID: 20937613
[TBL] [Abstract][Full Text] [Related]
6. Estimating the need for palliative radiotherapy for non-small cell lung cancer: A criterion-based benchmarking approach.
Jin CJ; Kong W; Mackillop WJ
Radiother Oncol; 2018 Sep; 128(3):541-547. PubMed ID: 29934108
[TBL] [Abstract][Full Text] [Related]
7. Estimating the need for palliative radiotherapy for brain metastasis: a benchmarking approach.
Kong W; Jarvis C; Mackillop WJ
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):83-91. PubMed ID: 25481789
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage.
Nilssen Y; Strand TE; Fjellbirkeland L; Bartnes K; Brustugun OT; O'Connell DL; Yu XQ; Møller B
Int J Cancer; 2016 Mar; 138(6):1350-60. PubMed ID: 26421593
[TBL] [Abstract][Full Text] [Related]
9. Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.
Nieder C; Dalhaug A; Haukland E; Mannsåker B; Pawinski A
Int J Circumpolar Health; 2017; 76(1):1270080. PubMed ID: 28452680
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.
Angelo K; Norum J; Dalhaug A; Pawinski A; Aandahl G; Haukland E; Engljähringer K; Nieder C
Anticancer Res; 2014 Feb; 34(2):877-85. PubMed ID: 24511026
[TBL] [Abstract][Full Text] [Related]
11. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study.
Huang J; Wai ES; Lau F; Blood PA
BMC Palliat Care; 2014; 13(1):49. PubMed ID: 25419181
[TBL] [Abstract][Full Text] [Related]
12. Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
Tseng YD; Gouwens NW; Lo SS; Halasz LM; Spady P; Mezheritsky I; Loggers E
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):21-29. PubMed ID: 29487025
[TBL] [Abstract][Full Text] [Related]
13. Utility of 30-day mortality as a quality metric for palliative radiation treatment: A population-based analysis from Queensland, Australia.
Guan TL; Kutzko JH; Lunn DP; Dunn NA; Burmeister BH; Dadwal P; Tran N; Holt TR
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):316-324. PubMed ID: 38500454
[TBL] [Abstract][Full Text] [Related]
14. Survival after palliative radiotherapy in geriatric cancer patients.
Nieder C; Angelo K; Haukland E; Pawinski A
Anticancer Res; 2014 Nov; 34(11):6641-5. PubMed ID: 25368269
[TBL] [Abstract][Full Text] [Related]
15. Palliative radiotherapy delivery by a dedicated multidisciplinary team facilitates early integration of palliative care: A secondary analysis of routinely collected health data.
Fairchild A; Hill J; Alhumaid M; Rau A; Ghosh S; Le A; Watanabe SM
J Med Imaging Radiat Sci; 2022 Jun; 53(2 Suppl):S51-S55. PubMed ID: 35210177
[TBL] [Abstract][Full Text] [Related]
16. Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.
Merchant SJ; Kong W; Mahmud A; Booth CM; Hanna TP
J Palliat Care; 2023 Apr; 38(2):157-166. PubMed ID: 35043749
[TBL] [Abstract][Full Text] [Related]
17. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
18. Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
Aksnessæther BY; Solberg A; Klepp OH; Myklebust TÅ; Skovlund E; Hoff SR; Vatten LJ; Lund JÅ
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):211-216. PubMed ID: 29534900
[TBL] [Abstract][Full Text] [Related]
19. Collaborating with the Community: Improving Patient Access to Palliative Radiation Therapy.
Loudon J; Rozanec N; Clement A; Woo R; Grant A; Murray J; Wells W
Pract Radiat Oncol; 2020; 10(1):1-7. PubMed ID: 31437605
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on survival after palliative radiotherapy.
Nieder C; Engljähringer K; Angelo K
Strahlenther Onkol; 2014 Nov; 190(12):1149-53. PubMed ID: 25022254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
